Feline Infectious Peritonitis (FIP): From Death Sentence to Treatable Disease

FIP was once a universally fatal disease in cats. The development of antiviral treatments has transformed it into a manageable condition, dramatically improving welfare outcomes.

Key Facts

FIP is caused by a mutation of feline coronavirus (FCoV) that allows the virus to replicate within macrophages and cause systemic disease.
It presents in two forms: wet (effusive) FIP with fluid accumulation in body cavities, and dry (non-effusive) FIP with granulomas in organs.
Until 2019, FIP was considered uniformly fatal with a median survival of weeks to months from diagnosis.
GS-441524 (a nucleoside analogue antiviral) and its prodrug molnupiravir/remdesivir analogues achieve remission in up to 85% of treated cats.
Treatment involves daily injections or oral medication for a minimum of 12 weeks, followed by a 12-week monitoring period.
GS-441524 is not licensed in all countries; in some jurisdictions, cats receive it via compounding pharmacies or treatment may require access to countries where it is available.
Cats in remission can live normal lives — many treated cats have now been in sustained remission for 3+ years.

Welfare Considerations

The transformation of FIP from a death sentence to a treatable disease is one of the most remarkable welfare advances in feline medicine in recent decades. Previously, cats diagnosed with FIP faced a welfare decision framework entirely about the timing of euthanasia. Now, treatment offers the genuine prospect of full remission and normal lifespan. The welfare burden of treatment — daily injections for 12+ weeks — is real but manageable for most cats and owners. Cats that respond to treatment show dramatic clinical improvement, often within days. The welfare failure now is unequal access: cost barriers and limited licensed availability in some countries mean cats that could be saved are not. Advocacy for licensing, access, and affordability of FIP treatment is a concrete welfare action.

What You Can Do

If your cat is diagnosed with FIP, immediately research GS-441524 treatment availability in your country.
Connect with FIP Warriors and other support groups for guidance on accessing treatment, particularly in countries with limited licensed availability.
Seek veterinary care from a vet experienced in FIP treatment — monitoring protocols are important for treatment success.
Complete the full treatment course (minimum 12 weeks) even if your cat appears recovered — premature discontinuation leads to relapse.
Support advocacy for licensing GS-441524 and equivalent FIP antivirals in all countries.
Donate to feline disease research organizations that have driven FIP treatment development and continue to improve access.